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The association between BMI and 
mortality using early adulthood 
BMI as an instrumental variable for 
midlife BMI
Marte K. R. Kjøllesdal  1, George Davey Smith2, Inger Ariansen3, Jonas Minet Kinge1,3, 
Eirik Degerud3 & Øyvind Næss1,3
The article aims to describe the association between midlife body mass index (BMI) and cardiovascular 
disease (CVD)- and all-cause mortality, and to use early adulthood BMI as an instrumental variable 
for midlife BMI, in order to obtain an estimate less distorted by midlife confounders and reverse 
causality. Data from Norwegian health surveys (1974–2003) (midlife BMI, smoking, blood pressure, 
total cholesterol, heart rate), Military Conscription Records, National Tuberculosis Screenings (early 
adulthood BMI), National Educational Registry and Cause of Death Registry were linked. Participants 
with data on BMI in early adulthood and midlife were included (n = 148.886). Hazard Ratio (HR) for CVD 
mortality was higher in men with midlife obesity relative to normal weight (HR = 1.46(95% CI 1.25, 
1.70). For all-cause mortality, HR was higher in those with obesity or underweight in midlife relative to 
normal weight (Men:HR = 1.19(95% CI 1.09, 1.29), HR = 2.49(95% CI 1.81, 3.43) Women:HR = 1.33(95% 
CI 1.13, 1.56), HR = 1.61(95% CI 1.22, 2.13)). In instrumental variable analyses, increased BMI became 
more strongly associated with CVD and all-cause mortality, and the increased risk of all-cause mortality 
among the underweight attenuated.
A number of studies have reported a J-shaped or U-shaped association between Body Mass Index (BMI) and 
mortality from all-causes and several specific causes, including cardiovascular diseases (CVD)1–5. Most of the evi-
dence on the risk associated with different levels of BMI comes from observational studies where measurements 
of BMI have been conducted in midlife. This may cause biased estimates on the role of BMI because BMI may 
become increasingly related to a number of confounders through the life course. Possible confounders could be 
health related behaviors and socioeconomic position (SEP)6,7. A probable important contributor to excess deaths 
in the lowest weight groups is illness, leading to both unintentional weight loss and increased mortality8. Further, 
weight trajectories over time could influence mortality risk. For example, people with previous obesity who have 
lost weight may upwardly bias mortality risk amongst those of normal weight8,9.
In order to circumvent these sources of bias, some have excluded the first years of follow-up, as ill people have 
a high risk of dying during these years10. However, illness causing low BMI can last for a longer period than the 
time excluded. This approach could also exclude deaths from illness caused by obesity, and thus attenuate the 
risk associated with high BMI8. Others adjust for possible confounders at baseline or exclude sub-groups, such as 
smokers. Assessment of confounders may, however be incomplete or inaccurate and adjusted analyses may retain 
considerable residual confounding11.
Instrumental variable analysis is an approach that may ideally handle misclassification, confounding and 
reverse causality, and thus provide an alternative estimate of the association between BMI and mortality. An 
instrumental variable is ideally associated with the risk factor of interest, and only through that, to the out-
come under study. It should not be related to confounding variables12. BMI is influenced by many factors acting 
over the life course, and also subject to genetic variation, such as the FTO-gene13. Studies based on the princi-
ples of Mendelian randomization14 have used genetic variants as instruments for BMI and thus strengthened 
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evidence for a causal effect of BMI on CVD15–17. Others have used offspring BMI and offspring blood pressure as 
instruments for own BMI and blood pressure to investigate its association with mortality18,19 and employment 
disability20.
Here we use an alternative instrument for own midlife BMI, namely own BMI in early adulthood, to estimate 
the association between BMI and all-cause mortality and CVD mortality. Both offspring weight and early adult-
hood BMI may be related to confounding factors. However, both mitigate against the problem of reverse causality 
by illness developing in adulthood, which may be the major problem in studies of BMI and mortality. An advan-
tage of early adulthood BMI is that it is often more available than offspring weight. Further, it does not exclude 
those who have no children, who may have different characteristics to those with children. The assumptions that 
should be in place for a variable to be used as an instrument are listed in Table 1.
In a large sample of Norwegian women and men with objective measurements of BMI in early adulthood and 
in midlife, as well as measurements of midlife CVD risk factors, we first aim to describe the association between 
midlife and early adulthood BMI and cardiovascular and all-cause mortality. Our second aim is to give an esti-
mate of the association between midlife BMI and all-cause and cardiovascular mortality, using BMI in early 
adulthood as an instrumental variable for BMI in midlife.
Methods
Variables. We included data from participants in national and regional Norwegian cardiovascular health 
surveys. In the Counties Study (1985–88), all men and women aged 35–49 years living in three different counties 
in Norway were invited to a survey21. In the Age 40 Program, inhabitants aged 40–44 years in all Norwegian 
counties, except for Oslo, were invited (1985–99)22. The Cohort Norway (CONOR) (1994–2003) is based on data 
from health surveys from all over Norway, with participants aged 20–103 years23. The attendance rate of the three 
surveys was 86%, 70% and 58% respectively23–25.
The surveys assessed CVD risk factors. Self-reported smoking status (“daily smoker” “not daily smoker”) and 
current treatment of hypertension was recorded. Blood pressure (BP, mmHg) was measured by automatic oscil-
lometric devices, and the average of the last two available measures defined BP. Resting heart rate was recorded 
(beats/minute). Non-fasting serum total cholesterol (TC, mmol/L) was initially measured by non-enzymatic, and 
later enzymatic, method. Non-enzymatic values were converted by a correction factor. BMI was calculated from 
objective measurements of weight and height (kilogram/meter2).
Men enrolled for military service, usually between 18 and 20 years of age, are obliged to complete several con-
script examinations, including objective measurements of height and weight. About 90% of Norwegian men par-
ticipate in the conscript examinations. Those not undergoing this appraisal include those who are physically and 
mentally disabled, have a criminal record or being abroad at the normal conscript age26. During 1963–1975, there 
was compulsory screening for tuberculosis in Norway, with population coverage for persons ≥15 years, which 
included objective measurements of height and weight. Health personnel travelled through the country carrying 
out these assesments27. BMI in early adulthood was calculated from weight and height at conscription, or if not 
available, from data from tuberculosis screenings for those aged 18–20 years at the time of examination. As the 
conscript data was almost exclusively men, our final sample consisted of about four times as many men as women. 
BMI both in early adulthood and midlife was categorized into weight groups; “underweight <18.5 kg/m2”, 
“normal weight 18.5 to <25 kg/m2”, “overweight 25 to <30 kg/m2” and obesity ≥30 kg/m2”.
Education was registered in the National Educational Registry and reported in National Population and 
Housing Censuses every 10th year from 1970 to 2011. A person’s highest attained educational level was classified 
as “≤9 years”, “10–11 years”, “12 years”, “13–16 years” and “>16 years”.
Data on underlying causes of death from CVD were obtained from the Norwegian Cause of Death Registry 
(ICD 8: 390–444.1, 444.3–458, 782.4, ICD-9: 390–459, ICD-10: I00-I99). Participants were followed up for 
all-cause and CVD mortality from their participation in a health survey in midlife until December 31st 2014.
Assumptions How assumptions are met in this study
The instrumental variable is 
associated with the risk factor 
of interest
In a number of studies, BMI in early life is positively associated with BMI later in life37. In our study, the 
F-test suggested the instrument was strong.
The instrumental variable is not 
influenced by the outcome
BMI in early adulthood is clearly not influenced by CVD mortality later in life, even though early process 
of disease stages could influence BMI.
The instrumental variable is not 
associated with confounding 
factors
Possible confounders of the association between BMI in midlife and subsequent CVD mortality are health 
related lifestyle, illness and socioeconomic position (SEP). Lifestyle and SEP in midlife cannot affect BMI 
in early adulthood directly. However, lifestyle and SEP in early life may influence lifestyle and SEP later in 
life. Thus, this approach is not sufficient to deal with all possible confounders tracking over the life course. 
CVD risk factors were found to be more strongly associated with BMI in midlife than in early adulthood, 
suggesting that associations with possible confounders are stronger in midlife than earlier. The instrument 
is not associated with disease in midlife influencing both BMI and mortality.
There is no pathway from the 
instrumental variable to the 
outcome, except through the 
risk factor.
We cannot demonstrate that there is no direct link between BMI in early adulthood and later CVD 
mortality. However, recent reviews of studies on the association between BMI in childhood and 
adolescence and later risk of CVD have found that there is little evidence for childhood obesity being 
an independent risk factor for adult cardiovascular risk, when adult BMI is accounted for38,39. Thus, 
the association between BMI in early adulthood and later CVD mortality appears to mainly reflect its 
association with BMI later in life.
Table 1. Adherence to instrumental variable assumptions.
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Sample. Data from health surveys, conscript data, tuberculosis screenings, the National Educational Registry 
and the Cause of Death Registry were linked using the unique national personal identity number. Participants 
from the health surveys turning 40–50 years at the year of their survey were selected. For those attending more 
than one health survey, data from their first survey was used. Only persons with data on BMI both in early 
adulthood and midlife were included. Those with missing data on education or any of risk factors were excluded 
(1.37%). The total number of participants was 148 886 (Fig. 1).
Statistical analyses. Cox proportional hazards regression models were used to calculate hazard ratio (HR) 
and 95% confidence intervals (CIs) for all-cause and cardiovascular mortality for each weight group (under-
weight, overweight and obesity), with normal weight as the reference, both in early adulthood and midlife. The 
models used age as underlying time, and robust variance estimation. Time (years of age) at risk was counted from 
when a participant entered the study. Individuals who did not die during follow up were censored at their age at 
the end of follow-up. Mean follow-up time was 19 years. Analyses were adjusted for education and CVD risk fac-
tors (smoking, serum total cholesterol, systolic and diastolic blood pressure, current treatment for hypertension, 
heart rate and height). Sensitivity analyses were carried out, with adjustment for index health survey and time of 
survey. Sensitivity analysis were also carried out on percentiles of BMI in midlife and early adulthood, looking at 
the highest and the lowest BMI groups, captured as the 10th and 90th percentile, as well as the 50–90th percentile 
compared to the 10–50th percentile. The association between cardiovascular death and BMI was explored using 
Poisson regression with robust variance estimation, and incidence rate ratios (IRR) were calculated.
BMI in midlife was instrumented by early adulthood BMI using an instrumental variable Poisson model based 
on a two-step GMM estimator (IV-poisson). Poissons regressions were adjusted for education. Prior research 
suggests that the relationship between body weight and health status is nonlinear2. To accommodate nonlineari-
ties in the relationship between mortality and BMI we estimated a second set of Poisson and IV-Poisson models 
in which the endogenous regressors were the participant’s BMI and BMI squared. As we had two endogenous 
regressors (BMI and BMI squared) we needed a second instrument and created a squared term in our IV regres-
sions by predicting the endogenous variable in our first stage regression, then used the square of the predicted 
term as an IV following (in two-stage least squares framework) Wooldridge28. Margin plots with predicted num-
ber of events were made for CVD and all-cause mortality based on Poisson and IV-Poisson regressions. To assess 
the extent of bias from confounders, we compared the covariate balance by levels of BMI and instrument, using 
Ordinary Least Square regression and instrumental variable analyses (Suppl. Fig. A), showing smaller bias when 
using the instrumental variable approach for all confounders except education (Hausman test)29. The F-test of the 
instrument, based on a linear first stage model, was 36803, considerably exceeding conventional criteria.
To demonstrate the practical implications of using the instrumental variable approach, we envisaged a sce-
nario where all participants increased their BMI by 2 units. The predicted number of events over the BMI scale 
was used to predict number of total deaths in our sample, both with measured BMI and with increased BMI, 
using the conventional and the instrumental variable approach.
Figure 1. Flow chart.
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STATA 14 was used for data analyses.
The study was approved by the Norwegian Regional Committees for Medical and Health Research Ethics 
(REK) (2012/827). Written informed consent was obtained from participants in the Age 40 Program and 
CONOR. Participants in the Counties studies gave written permission for their results to be sent to their physi-
cian. Permission to be absolved from this professional secrecy has been granted and concession to handle this 
personal health information has been given by the authorities. The health studies have been conducted in full 
accordance with the World Medical Association Declaration of Helsinki.This study is part of a research project 
at the Norwegian Institute of Public Health (NIPH). The linked data used in the study can be made available on a 
remote access platform to researchers who become project members. The project is responsible for obtaining for 
new members the necessary approvals from the Regional Ethics Committee South-East as well as to ensure that 
the new member sign a confidentiality agreement with Statistics Norway. It is also possible to apply for data from 
NIPH and Statistics Norway.
Results
The majority of participants were normal weight in early adulthood, however, in midlife more than half of men 
and about one third of women had overweight or obesity (Table 2). The number of CVD deaths during follow up 
was 1473 among men and 199 among women, and the total number of deaths was 5829 and 1709, respectively. 
The risk factors were more strongly associated with BMI in midlife than in early adulthood (Table 3). A stronger 
association between covariates and BMI in midlife than in early adulthood was seen in all weight categories, 
except for smoking among those with overweight and obesity, and diastolic BP among those with overweight 
(Suppl. Table A).
Weight categories and mortality. Table 4 shows the association between CVD- and all-cause mortality 
and BMI in early adulthood and midlife. Among men, those with overweight (HR = 1.37 (95%CI 1.16, 1.62)) or 
obesity (HR = 2.70 (95% CI 1.88, 3.78)) in early adulthood, as well as those who with underweight (HR = 2.38 
Men
N = 116 777
Women
N = 32 109
Birth year, min max 1943–1963 1943–1962
Examination year, min max 1985–2003 1985–2003
Age by examination, mean (SD) 41.4 (1.3) 41.7 (1.4)
BMI in midlife (40–50 years), mean (SD) 26.0 (3.3) 24.3 (3.9)
BMI in early adulthood (18–20 years), mean (SD) 21.6 (2.3) 21.8 (2.7)
Weight category, early adulthood, n (%)
   Underweight 6576 (6) 2253 (7)
   Normal weight 102 017 (87) 26 342 (82)
   Overweight 7496 (6) 3192 (10)
   Obesity 694 (1) 322 (1)
Weight category, midlife, n (%)
   Underweight 269 (0) 556 (2)
   Normal weight 47 984 (41) 20 621 (64)
   Overweight 56 082 (48) 8314 (26)
   Obesity 12 442 (11) 2618 (8)
Education, n (%)
   ≤9 years 15 217 (13) 6145 (19)
   10–11 years 34 873 (30) 14 593 (45)
   12 years 36 381 (31) 4632 (14)
   13–15 years 21 484 (18) 6132 (19)
   ≥16 years 8822 (8) 607 (2)
CVD mortality, n (%) 1473 (1) 199 (0)
All-cause mortality, n (%) 5829 (5) 1709 (5)
Age at death, mean (SD), min max 54.1 (6.0) 39–68 56.1 (6.3) 40–68
Age at CVD death, mean (SD), min max 54.0 (6.0) 39–68 56.5 (6.3) 41–68
Midlife risk factors
Blood pressure (mmHg)
   Systolic, mean (SD) 135 (13) 127 (14)
   Diastolic, mean (SD) 80 (10) 78 (10)
Heart rate (beats/min), mean (SD) 72 (12) 78 (13)
Cholesterol (mmol/L), mean (SD) 5.8 (1.1) 5.5 (1.0)
Height (cm), mean (SD) 179.3 (6.4) 165.8 (5.7)
Daily smoking, n (%) 44 459 (38) 13 074 (41)
Table 2. Characteristics of the sample, men and women. BMI: Body Mass Index CVD: Cardiovascular Disease.
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(95% CI 1.12, 5.05)) or obesity in midlife (HR = 1.46 (95% CI 1.25, 1.70)), had higher HR of CVD mortality than 
normal weight men, after adjustment for education and CVD risk factors. These differences were not seen among 
women.
In midlife, all-cause mortality risk was higher among those with underweight and obesity than among 
normal weight men (HR = 2.49 (95% CI 1.81, 3.43), HR = 1.19 (95% CI 1.09, 1.29), respectively) and normal 
weight women (HR = 1.61 (95% CI 1.22, 2.13), HR = 1.33 (95% CI 1.13, 1.56), respectively), when adjusted for 
education and CVD risk factors. Men with overweight had a lower mortality risk compared to normal weight 
men (HR = 0.91 (95% CI 0.86, 0.96)). In early adulthood, all-cause mortality was also higher among individuals 
with obesity in comparison to normal weight individuals among both men (HR = 1.82 (95% CI 1.45, 2.27)) and 
women (HR = 1.71 (95% CI 1.22, 2.38)) and among men with overweight (HR = 1.21 (95% CI 1.11, 1.33)). We 
experimented with one extra weight group, namely BMI > = 35 kg/m2. The results were in essence the same, 
however more pronounced in the highest weight group than among those with BMI 30–34.9 kg/m2. Due to few 
participants with a BMI > = 35 in early adulthood, we analyzed obesity as one group.
BMI (kg/m2)
Early adulthood 
(18–20 years)
Midlife  
(40–50 years)
β (95% CI)
Serum total cholesterol (mmol/L) 0.03 (0.02, 0.03) 0.06 (0.06, 0.07)
Systolic Blood Pressure (mmHg) 0.57 (0.54, 0.60) 1.13 (1.11, 1.15)
Diastolic Blood Pressure (mmHg) 0.39 (0.37, 0.41) 0.72 (0.71, 0.74)
Heart Rate (beats/min) 0.07 (0.04, 0.09) 0.20 (0.19, 0.22)
BMI, early adulthood (kg/m2) 0.38 (0.38, 0.39)
Odds Ratio (95% CI)
Smoking, ref: no 1.01 (1.01, 1.02) 0.94 (0.94, 0.94)
Current treatment for hypertension, ref: no 1.16 (1.15, 1.17) 1.19 (1.18, 1.20)
Table 3. Crude associations between risk factors for cardiovascular disease and Body Mass Index (BMI) 
measured in midlife and in early adulthood. Total cholesterol, systolic and diastolic blood pressure, heart rate, 
BMI early adulthood: linear regressions. Smoking and current treatment for hypertension: logistic regressions.
CVD mortality
Model 1 Model 2
HR (95% CI)
Model 1 Model 2 Model 3Model 3
Men Women
Midlife
   Underweight 2.54 (1.21, 5.35) 2.24 (1.06, 4.72) 2.38 (1.12, 5.05) 2.45 (1.45, 5.25) 2.23 (1.04, 4.80) 2.09 (0.96, 4.51)
   Normal weight 1 1 1 1 1 1
   Overweight 1.10 (0.98, 1.24) 1.05 (0.94, 1.19) 0.92 (0.82, 1.04) 1.19 (0.86, 1.66) 1.11 (0.80, 1.54) 0.88 (0.63, 1.24)
   Obesity 2.40 (2.08, 2.77) 2.18 (1.88, 2.51) 1.46 (1.25, 1.70) 2.31 (1.55, 3.44) 2.00 (1.34, 2.97) 1.21 (0.78, 1.89)
Early adulthood
   Underweight 1.16 (0.93, 1.45) 1.12 (0.89, 1.39) 1.17 (0.94, 1.46) 1.11 (0.64, 1.92) 1.02 (0.59, 1.77) 1.07 (0.62, 1.86)
   Normal weight 1 1 1 1 1 1
   Overweight 1.92 (1.63, 2.36) 1.79 (1.52, 2.11) 1.37 (1.16, 1.62) 1.32 (0.86, 2.01) 1.20 (0.79, 1.84) 0.95 (0.62, 1.46)
   Obesity 4.41 (3.12, 6.23) 3.86 (2.73, 5.45) 2.70 (1.88, 3.78) 3.79 (1.78, 1.10) 3.06 (1.44, 6.50) 1.81 (0.82, 3.97)
All-cause Men Women
Midlife
   Underweight 3.09 (2.25, 4.25) 2.77 (2.01, 3.81) 2.49 (1.81, 3.43) 1.93 (1.46, 2.55) 1.85 (1.40, 2.44) 1.61 (1.22, 2.13)
   Normal weight 1 1 1 1 1 1
   Overweight 0.95 (0.90, 1.01) 0.93 (0.87, 0.98) 0.91 (0.86, 0.96) 1.00 (0.90, 1.13) 0.97 (0.86, 1.08) 0.94 (0.84, 1.06)
   Obesity 1.49 (1.38, 1.61) 1.37 (0.27, 1.49) 1.19 (1.09, 1.29) 1.56 (1.34, 1.82) 1.45 (1.24, 1.69) 1.33 (1.13, 1.56)
Early adulthood
   Underweight 1.14 (1.02, 1.27) 1.11 (0.99, 1.23) 1.10 (0.98, 1.22) 0.10 (0.91, 1.32) 1.05 (0.87, 1.27) 1.03 (0.86, 1.24)
   Normal weight 1 1 1 1 1 1
   Overweight 1.45 (1.33, 1.59) 1.37 (1.25, 1.50) 1.21 (1.11, 1.33) 1.25 (1.08, 1.45) 1.19 (1.03, 1.38) 1.10 (0.94, 1.27)
   Obesity 2.47 (0.97, 3.09) 2.20 (1.76, 2.75) 1.82 (1.45, 2.27) 2.26 (1.62, 3.14) 2.01 (1.45, 2.81) 1.71 (1.22, 2.38)
Table 4. Hazard ratios (HR) for all-cause and cardiovascular (CVD) mortality according to weight categories 
from Cox regressions. Model 1: crude, Model 2: adjusted for education, Model 3: adjusted for education and risk 
factors. P-value for difference in observational estimates and IV estimates <0.01 for all-cause mortality among 
women and men, and cardiovascular mortality among men.
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To account for different distribution of early adulthood and midlife BMI, we ran sensitivity analyses on per-
centiles of observed BMI in midlife and early adulthood, examining the highest and the lowest BMI groups, 
captured as the 10th and 90th percentile, as well as the 50–90th percentile compared to the 10–50th (Suppl. Table B). 
The results remained essentially the same. However, the tendency that HR estimates for obesity compared to nor-
mal weight were higher in early adulthood than in midlife were not replicated when comparing the 90th percentile 
to the 10–50th percentile. Further, an association between underweight in midlife among men and obesity in early 
adulthood among women and all-cause mortality was not replicated comparing the 10th and the 90th percentile 
to the 10–50th percentile.
BMI and mortality. Higher BMI in early adulthood and in midlife was associated with an increased CVD 
mortality among both men and women (Table 5).
Among both women and men, higher BMI in early adulthood was associated with higher all-cause mortal-
ity (Table 5). Midlife BMI was associated with higher all-cause mortality only in men. Using the instrumental 
Cardiovascular mortality
Coefficient (95% CI) IRR Coefficient (95% CI) IRR
Men Women
Early adulthood BMI 0.09 (0.07, 0.11) 1.10 0.06 (0.01, 0.11) 1.06
Midlife BMI 0.07 (0.05, 0.08) 1.07 0.05 (0.01, 0.08) 1.05
Early adulthood BMI as instrumental variable for BMI 0.10 (0.08, 0.13) 1.09 0.07 (0.02, 0.12) 1.04
All-cause mortality Men Women
Early adulthood BMI 0.05 (0.04, 0.06) 1.05 0.03 (0.01, 0.04) 1.03
Midlife BMI 0.01 (0.01, 0.02) 1.01 0.01 (−0.00, 0.02) 1.01
Early adulthood BMI as instrumental variable for BMI 0.06 (0.04, 0.07) 1.05 0.03 (0.01, 0.05) 1.03
Table 5. Associations between Body Mass Index (BMI) and cardiovascular mortality and all-cause mortality, 
Poisson regression coefficients and incidence rate ratio (IRR) from Poisson regressions (additive residuals). 
Instrumental variable analyses, using early adulthood BMI as an instrument for midlife BMI, ivpoisson 
regressions (multiplicative residuals) in STATA. All associations adjusted for education.
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Figure 2. (A) Predictive margins for cardiovascular mortality by (a) body mass index (BMI) in midlife and 
(b) BMI in midlife instrumented by BMI in early adulthood, among men and women. Adjusted for education. 
(B) Predictive margins for all-cause mortality by (a) body mass index (BMI) in midlife and (b) BMI in midlife 
instrumented by BMI in early adulthood, among men and women. Adjusted for education.
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variable approach, midlife BMI was also associated with higher all-cause mortality among women. The estimates 
from the instrumental variable analyses were higher than the observational estimates for all-cause mortality 
among women and men, and for cardiovascular mortality among men.
Figure 2 depicts the relationships between BMI in midlife and CVD and all-cause mortality when assessed 
using the conventional approach and the instrumental variable approach. For CVD, the associations were 
J-shaped among the women and linear among the men. The association between midlife BMI and CVD mortality 
was stronger with the instrumental variable approach than with the conventional approach.
For all-cause mortality, a U-shaped association with midlife BMI was seen using the conventional approach. 
With the instrumental variable approach, the association between BMI and all-cause mortality was slightly 
stronger than in conventional analyses, and mortality in lower weight groups did not differ considerably from 
normal weight subjects. The lowest mortality risk was at lower BMI levels using the instrumental variable 
approach than the conventional approach. It was in the upper end of the normal weight range among women and 
in the middle of the normal weight range among men.
In sensitivity analyses, adjusted for index survey, and year of survey, estimates were not markedly changed 
(results not shown). Finally, we reran our IV-models using linear two-stage least squares and this did not change 
the conclusions.
To evaluate the impact of using either the conventional approach or the instrumental variable approach, we 
imposed a scenario in which the midlife BMI in the study population increased with two units, and compared 
the number of predicted deaths at different levels of BMI with the two approaches (Fig. 3). The instrumental 
variable approach predicted that more subjects would die from overweight and obesity than the conventional 
approach.
Figure 3. Number of total deaths over BMI units, measured BMI and in a scenario were all participants have 
gained weight according to 2 BMI units, using conventional and instrumental variable approach. Based on 
predicted number of events. (a) predicted number of deaths at each BMI unit and (b) cumulative predicted 
number of events.
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Discussion
This study suggests that the effect of BMI on all-cause mortality, and especially cardiovascular mortality, might have 
been previously underestimated. Stronger estimates in instrumental variable analyses may be due to circumvention 
of midlife confounders, and to the included aspect of exposure over time. The results suggest that confounding 
caused by illness-induced low weight was reduced by using early adulthood BMI as an instrument for midlife BMI.
The study had a large sample of men and women from all areas in Norway, with measured data on BMI in 
early adulthood and midlife. The majority of previous studies on weight at different stages of the life course have 
been based on self-report of weight, at least at one time point30–33. Use of register data largely eliminates problems 
related to loss to follow-up. Moreover, the health surveys with data on risk factors had a reasonable response rate. 
However, many subjects did not reach a high age where CVD mortality is more probable during follow-up and 
our results are essentially confined to premature CVD- and overall mortality. Associations between BMI and 
mortality changes with age3. Therefore, our estimated associations would probably change if we followed the 
participants into older ages.
The shape of the naïve observational associations between BMI and CVD mortality1. and between BMI and 
all-cause mortality2,3,5, are in line with previous studies. The increased all-cause mortality with increasing weight 
is largely attributable to CVD1. Blood pressure, smoking, and to some extent LDL cholesterol, have been found to 
explain a large share of the association between BMI and CVD in adults34,35.
Smoking could be one explanation for higher mortality in low weight groups. Removing smokers from analy-
ses has attenuated the increased risk in low weight groups in previous studies2. In our study, adjustment for CVD 
risk factors, including smoking, did not substantially change the increased risk of all-cause mortality among 
underweight.
When adjusted for education, the increased risk of CVD mortality among women with obesity was no longer 
observed. Both obesity and CVD mortality are more common in lower SEP groups, so education is a plausible 
confounder in this association7. A confounding effect of risk factors, as well as of SEP, on the association between 
BMI and mortality is probably related to health behavior during the life course. The effect of such possible con-
founders, both adjusted for (smoking) and not adjusted for (e.g. diet or alcohol consumption) in our study is not 
fully removed with the instrumental variable design. They were however, substantially smaller than in conven-
tional analyses (Suppl. Fig. A). Further, in the instrumental variable analyses, exposure to high or low BMI over 
the adult life was taken into account, possibly reflecting a genetic disposition to a level of BMI, which may partly 
explain a stronger associations between BMI and CVD mortality in these analyses.
Less excess deaths among underweight when using the instrumental variable approach than in conventional 
analyses suggests confounding by midlife factors when using midlife BMI. A stronger association between BMI 
and CVD mortality in instrumental variable analyses also indicates previous underestimation of the magnitude 
of the relationship. This is in line with studies using offspring weight as an instrument for own weight in relation 
to mortality18,19. It is also in line with studies based on Mendelian randomization, using genetic variants as instru-
mental variables for BMI15–17. Other outcomes, such as lung disease mortality, may be more strongly influenced 
by confounding of current illness than CVD. Using instrumental variable analyses on more causes of death in 
relation to BMI could further shed light on the extent of bias from current illness and other confounders.
A pertinent question has been whether subjects with overweight, in addition to subjects with obesity, are at 
increased risk of CVD and all-cause mortality. Several studies have reported that obesity appears to increase the 
risk of CVD, but not overweight1,2,36. When applying the instrumental variable approach, however, we observed 
increased risk of CVD and all-cause mortality also in the overweight range. Importantly, predictions using the 
instrumental variable approach suggest that the preventive health effect of maintaining a lower population mean 
BMI is substantially higher than would be predicted using the conventional approach.
Conclusion
The study suggested a stronger association between BMI and mortality when early life BMI was used as an instru-
ment for midlife BMI, possibly because of less influence of confounding factors, and the inclusion of the aspect 
of a lifelong exposure.
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